Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients
Authors:
- M L De RosaMRM L De Rosa
- P CardacePCP Cardace
- M RossiMRM Rossi
- A BaianoABA Baiano
- A de CristofaroACA de Cristofaro
- 1 February 2002
- journal article
- clinical trial
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 16 (2) , 133-140
Abstract
Journal of Human Hypertension is exclusively concerned with all clinical aspects of human hypertension. The journal publishes fully refereed original research papers from around the world.Keywords
This publication has 15 references indexed in Scilit:
- Rationale for the Chemical Development of Angiotensin II Receptor AntagonistsAmerican Journal of Hypertension, 1992
- Clinical Experience With the Angiotensin II Receptor Antagonist LosartanAmerican Journal of Hypertension, 1992
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992
- Effects of the Nonpeptide Angiotensin II Receptor Antagonist DuP 753 on Blood Pressure and Renal Functions in Spontaneously Hypertensive PH DogsAmerican Journal of Hypertension, 1991
- Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.Circulation, 1991
- Nonpeptide angiotensin II receptor antagonistsTrends in Pharmacological Sciences, 1991
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Split Renal Function Testing Using Tc-99m DTPAClinical Nuclear Medicine, 1983
- Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous)American Journal of Roentgenology, 1982
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978